This inventor holds 1 USPTO granted patent. Top assignees: Genencor International, Inc., Lipitek, Inc.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 422 
1 out of 1 Years Active: 1996
Title: Kirupathevy Shanmuganathan: Innovator in Nucleoside Research
Introduction
Kirupathevy Shanmuganathan is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of nucleosides. His work has implications for treating various diseases in mammals.
Latest Patents
Shanmuganathan holds a patent for L-ribofuranosyl nucleosides. This invention relates to α and β L-ribofuranosyl nucleosides, processes for their preparation, pharmaceutical compositions containing them, and methods of using them to treat various diseases in mammals. His innovative approach in this area has the potential to advance therapeutic options.
Career Highlights
Throughout his career, Shanmuganathan has worked with prominent companies such as Genencor International, Inc. and Lipitek, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in his field.
Collaborations
Some of his notable coworkers include Alexander L. Weis and Charles T. Goodhue. Their collaborative efforts have likely enriched the research environment and fostered innovation in nucleoside development.
Conclusion
Kirupathevy Shanmuganathan's contributions to nucleoside research exemplify the impact of innovative thinking in pharmaceuticals. His work continues to influence the treatment of diseases, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile